Results 11 to 20 of about 471,570 (210)

Localized scleroderma – current treatment options

open access: yesPrzegląd Dermatologiczny, 2017
Localized scleroderma (morphea) is a connective tissue disease that affects the skin, subcutaneous tissue and underlying tissues including the fasciae, muscles and bones. The treatment of localized scleroderma depends on the clinical form of the disease,
Katarzyna Wolska-Gawron   +2 more
doaj   +2 more sources

Localized scleroderma – classification and tools used for the evaluation of tissue damage and disease activity/severity [PDF]

open access: yesPrzegląd Dermatologiczny, 2017
Localized scleroderma is a rare autoimmune disorder affecting the dermis, subcutaneous tissue and deeper structures. The course of localized scleroderma includes three stages: early inflammation, progressive sclerosis and atrophy. The active stage of the
Katarzyna Wolska-Gawron   +1 more
doaj   +2 more sources

Localized scleroderma: A rare clinical entity

open access: yesJournal of Indian Academy of Oral Medicine and Radiology, 2014
Localized Scleroderma (LS), which is also referred to as morphea, is an inflammatory disease that leads to diffuse or localized fibrotic and atrophic skin hardening.
Ranjana Garg   +2 more
doaj   +2 more sources

Modern methods of a localized scleroderma diagnostics [PDF]

open access: yesСаратовский научно-медицинский журнал, 2016
Localized scleroderma (LS) is a disease that is characterized by the appearance of inflammatory, sclerotic and/or atrophic changes in the affected areas of the skin and underlying tissues.
Moiseyev А.А., Utz S.R.
doaj   +1 more source

Localized scleroderma is an autoimmune disorder [PDF]

open access: yesRheumatology, 2005
There have been many studies suggesting that localized scleroderma has a strong autoimmune background, although the lesions are usually limited to the skin and subcutaneous tissue. Here we summarize previous data on the autoimmunity of localized scleroderma, mostly published in the last two decades, because there has not been a review paper summarizing
K, Takehara, S, Sato
openaire   +5 more sources

Histological Changes of Linear Scleroderma “en Coup de Sabre”

open access: yesЛьвівський клінічний вісник, 2014
Introduction. Scleroderma is a chronic disease of unknown aetiology characterized by skin fibrosis and is divided into two clinical entities: localized scleroderma and systemic sclerosis.
M. Мaтошвілі   +3 more
doaj   +2 more sources

Localized Scleroderma, Systemic Sclerosis and Cardiovascular Risk: A Danish Nationwide Cohort Study [PDF]

open access: yesActa Dermato-Venereologica, 2017
Recent findings indicate that patients with systemic sclerosis have an increased risk of cardiovascular disease. To determine whether patients with systemic sclerosis or localized scleroderma are at increased risk of cardiovascular disease, a cohort ...
Jeanette Halskou Hesselvig   +5 more
doaj   +2 more sources

Evaluation of mean platelet volume in localized scleroderma [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2017
: Background: Localized scleroderma is a chronic inflammatory skin disease characterized by sclerosis of the dermis and subcutaneous tissue. Platelets play an important role in inflammation.
Anil Gulsel Bahali   +5 more
doaj   +2 more sources

The role of Borrelia burgdorferi infection in scleroderma

open access: yesRheumatology, 2014
Borrelia burgdorferi , a Gram-negative, spiral-shaped bacterium transmitted to humans via tick bites, is the etiologic agent of borreliosis (Lyme disease) with diverse clinical manifestations. There are several types of pathological lesions in the course
Żaneta Smoleńska   +3 more
doaj   +2 more sources

Localized scleroderma in a newborn (case report) [PDF]

open access: yesРМЖ. Мать и дитя, 2022
N.I. Akhmina1, P.S. Utkin2, M.P. Shalatonin3, Zh.L. Chabaidze1, A.A. Dement’ev1, A.L. Zaplatnikov1 1Russian Medical Academy of Continuous Professional Education, Moscow,   Russian Federation 2Children’s Infectious Clinical Hospital
N.I. Akhmina   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy